

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 6.31935322 |
| 2 | exogenous drug catabolic process (GO:0042738) | 5.97720660 |
| 3 | drug catabolic process (GO:0042737) | 5.69377911 |
| 4 | negative regulation of cholesterol transport (GO:0032375) | 5.04071696 |
| 5 | negative regulation of sterol transport (GO:0032372) | 5.04071696 |
| 6 | response to pheromone (GO:0019236) | 4.75171927 |
| 7 | glyoxylate metabolic process (GO:0046487) | 4.30500408 |
| 8 | oxidative demethylation (GO:0070989) | 4.14483297 |
| 9 | positive regulation of fatty acid transport (GO:2000193) | 4.04020982 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.02667691 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.02667691 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.02667691 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 3.97493843 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 3.91673264 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.91673264 |
| 16 | arginine metabolic process (GO:0006525) | 3.90443492 |
| 17 | cellular ketone body metabolic process (GO:0046950) | 3.88814833 |
| 18 | intestinal cholesterol absorption (GO:0030299) | 3.88364622 |
| 19 | positive regulation of icosanoid secretion (GO:0032305) | 3.85734992 |
| 20 | positive regulation of prostaglandin secretion (GO:0032308) | 3.78342407 |
| 21 | omega-hydroxylase P450 pathway (GO:0097267) | 3.75422973 |
| 22 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.72096094 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 3.70503221 |
| 24 | epoxygenase P450 pathway (GO:0019373) | 3.67668792 |
| 25 | regulation of fibrinolysis (GO:0051917) | 3.62433187 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 3.58675868 |
| 27 | arginine catabolic process (GO:0006527) | 3.58222576 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.57905784 |
| 29 | complement activation, alternative pathway (GO:0006957) | 3.52872069 |
| 30 | S-adenosylmethionine metabolic process (GO:0046500) | 3.46497275 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 3.44916609 |
| 32 | ketone body metabolic process (GO:1902224) | 3.43105230 |
| 33 | regulation of glucokinase activity (GO:0033131) | 3.42177315 |
| 34 | regulation of hexokinase activity (GO:1903299) | 3.42177315 |
| 35 | regulation of protein activation cascade (GO:2000257) | 3.41270096 |
| 36 | imidazole-containing compound metabolic process (GO:0052803) | 3.39672490 |
| 37 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.37177579 |
| 38 | alkaloid metabolic process (GO:0009820) | 3.37056671 |
| 39 | tryptophan metabolic process (GO:0006568) | 3.36969015 |
| 40 | blood coagulation, intrinsic pathway (GO:0007597) | 3.32231420 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 3.31984965 |
| 42 | ethanol oxidation (GO:0006069) | 3.28410089 |
| 43 | cysteine metabolic process (GO:0006534) | 3.27659042 |
| 44 | protein carboxylation (GO:0018214) | 3.26675861 |
| 45 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.26675861 |
| 46 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.23732112 |
| 47 | regulation of complement activation (GO:0030449) | 3.22852437 |
| 48 | synaptic transmission, cholinergic (GO:0007271) | 3.22737871 |
| 49 | drug metabolic process (GO:0017144) | 3.22636662 |
| 50 | L-fucose catabolic process (GO:0042355) | 3.20745092 |
| 51 | fucose catabolic process (GO:0019317) | 3.20745092 |
| 52 | L-fucose metabolic process (GO:0042354) | 3.20745092 |
| 53 | regulation of prostaglandin secretion (GO:0032306) | 3.20200130 |
| 54 | bile acid biosynthetic process (GO:0006699) | 3.17592550 |
| 55 | triglyceride homeostasis (GO:0070328) | 3.17581878 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.17581878 |
| 57 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.12078981 |
| 58 | L-phenylalanine metabolic process (GO:0006558) | 3.12078981 |
| 59 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.11351249 |
| 60 | detection of light stimulus involved in visual perception (GO:0050908) | 3.11351249 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 3.11003910 |
| 62 | NAD biosynthetic process (GO:0009435) | 3.07056083 |
| 63 | kynurenine metabolic process (GO:0070189) | 3.06834602 |
| 64 | DNA deamination (GO:0045006) | 3.05975825 |
| 65 | positive regulation of organic acid transport (GO:0032892) | 3.03973868 |
| 66 | protein-lipid complex remodeling (GO:0034368) | 3.03646649 |
| 67 | macromolecular complex remodeling (GO:0034367) | 3.03646649 |
| 68 | plasma lipoprotein particle remodeling (GO:0034369) | 3.03646649 |
| 69 | sulfation (GO:0051923) | 3.03174640 |
| 70 | tyrosine metabolic process (GO:0006570) | 2.98681529 |
| 71 | nucleobase catabolic process (GO:0046113) | 2.89884947 |
| 72 | reverse cholesterol transport (GO:0043691) | 2.89549276 |
| 73 | amino-acid betaine metabolic process (GO:0006577) | 2.87078173 |
| 74 | alpha-amino acid catabolic process (GO:1901606) | 2.85084731 |
| 75 | aromatic amino acid family metabolic process (GO:0009072) | 2.82314276 |
| 76 | amine catabolic process (GO:0009310) | 2.78732783 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 2.78732783 |
| 78 | regulation of icosanoid secretion (GO:0032303) | 2.75374256 |
| 79 | bile acid metabolic process (GO:0008206) | 2.74757668 |
| 80 | bile acid and bile salt transport (GO:0015721) | 2.74104878 |
| 81 | aldehyde catabolic process (GO:0046185) | 2.73634590 |
| 82 | heme transport (GO:0015886) | 2.72146587 |
| 83 | cholesterol efflux (GO:0033344) | 2.72094105 |
| 84 | peptidyl-glutamic acid modification (GO:0018200) | 2.67979289 |
| 85 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.67125795 |
| 86 | cellular glucuronidation (GO:0052695) | 2.65601427 |
| 87 | negative regulation of telomere maintenance (GO:0032205) | 2.62303938 |
| 88 | kidney morphogenesis (GO:0060993) | 2.61541131 |
| 89 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.61204426 |
| 90 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.61204426 |
| 91 | ethanol metabolic process (GO:0006067) | 2.60874145 |
| 92 | L-methionine salvage (GO:0071267) | 2.60296922 |
| 93 | L-methionine biosynthetic process (GO:0071265) | 2.60296922 |
| 94 | amino acid salvage (GO:0043102) | 2.60296922 |
| 95 | primary amino compound metabolic process (GO:1901160) | 2.60020996 |
| 96 | negative regulation of astrocyte differentiation (GO:0048712) | 2.59048678 |
| 97 | regulation of cholesterol esterification (GO:0010872) | 2.58528530 |
| 98 | indole-containing compound metabolic process (GO:0042430) | 2.58440056 |
| 99 | uronic acid metabolic process (GO:0006063) | 2.57793328 |
| 100 | glucuronate metabolic process (GO:0019585) | 2.57793328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.99816136 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54122380 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.14384208 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.75552276 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.47011926 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.45380699 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.27628826 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.12871217 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.98507320 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87848625 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.80037580 |
| 12 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78655689 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71852620 |
| 14 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.71111684 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.64983525 |
| 16 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64198307 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.60916669 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58362455 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58191007 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57602872 |
| 21 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54913785 |
| 22 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.54563120 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48883752 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47619136 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47292129 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46492661 |
| 27 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.45482463 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45309785 |
| 29 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.42344582 |
| 30 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.41178501 |
| 31 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41178501 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40665093 |
| 33 | NCOR_22424771_ChIP-Seq_293T_Human | 1.39933297 |
| 34 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.38866501 |
| 35 | AR_20517297_ChIP-Seq_VCAP_Human | 1.35579417 |
| 36 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35453445 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.34543562 |
| 38 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.32072715 |
| 39 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.32072715 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32011486 |
| 41 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.31876130 |
| 42 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31592781 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31418743 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28889377 |
| 45 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.28880290 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28330652 |
| 47 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.28130037 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28041653 |
| 49 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.27805481 |
| 50 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.27196396 |
| 51 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.26576001 |
| 52 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.26149556 |
| 53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25796811 |
| 54 | ERA_21632823_ChIP-Seq_H3396_Human | 1.25770605 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25221452 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23140680 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.23022919 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22902117 |
| 59 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21832604 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21449833 |
| 61 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20562881 |
| 62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.20436959 |
| 63 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.20436959 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.19497341 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19246486 |
| 66 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.18613743 |
| 67 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.18336751 |
| 68 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17372772 |
| 69 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17372772 |
| 70 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.16826472 |
| 71 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16612413 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16541361 |
| 73 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.16436284 |
| 74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15508662 |
| 75 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14479901 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14289497 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14192523 |
| 78 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.12683417 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12362441 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12121451 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10713757 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.10224826 |
| 83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09594807 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08548253 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08039107 |
| 86 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07578067 |
| 87 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.07271499 |
| 88 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.06139449 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05930974 |
| 90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05893483 |
| 91 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05622440 |
| 92 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.05500341 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05477271 |
| 94 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.05422758 |
| 95 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.03007581 |
| 96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.02613859 |
| 97 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02582474 |
| 98 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02578655 |
| 99 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02377738 |
| 100 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02205523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 4.88890250 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.17973924 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 3.94612084 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.25042220 |
| 5 | MP0005360_urolithiasis | 3.04656843 |
| 6 | MP0002102_abnormal_ear_morphology | 2.95222546 |
| 7 | MP0005365_abnormal_bile_salt | 2.93086722 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.41366916 |
| 9 | MP0002638_abnormal_pupillary_reflex | 2.30053608 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.29665781 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.15455551 |
| 12 | MP0005646_abnormal_pituitary_gland | 1.96690787 |
| 13 | MP0006292_abnormal_olfactory_placode | 1.94531565 |
| 14 | MP0002735_abnormal_chemical_nociception | 1.92174323 |
| 15 | MP0003011_delayed_dark_adaptation | 1.90295955 |
| 16 | MP0001986_abnormal_taste_sensitivity | 1.89487456 |
| 17 | MP0004885_abnormal_endolymph | 1.85414664 |
| 18 | MP0003252_abnormal_bile_duct | 1.83707643 |
| 19 | MP0003646_muscle_fatigue | 1.82649640 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.80174319 |
| 21 | MP0005332_abnormal_amino_acid | 1.73677373 |
| 22 | MP0003122_maternal_imprinting | 1.68757566 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 1.61767329 |
| 24 | MP0008872_abnormal_physiological_respon | 1.59609971 |
| 25 | MP0004147_increased_porphyrin_level | 1.57326365 |
| 26 | MP0009840_abnormal_foam_cell | 1.55283751 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.54156789 |
| 28 | MP0004133_heterotaxia | 1.53158200 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.50983022 |
| 30 | MP0009745_abnormal_behavioral_response | 1.50339013 |
| 31 | MP0000566_synostosis | 1.46625583 |
| 32 | MP0004043_abnormal_pH_regulation | 1.43895419 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.39980958 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.38166571 |
| 35 | MP0003136_yellow_coat_color | 1.34520742 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.32402990 |
| 37 | MP0005448_abnormal_energy_balance | 1.29404793 |
| 38 | MP0004742_abnormal_vestibular_system | 1.29323655 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.27318936 |
| 40 | MP0004142_abnormal_muscle_tone | 1.25056364 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.21372110 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.20964108 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.19207694 |
| 44 | MP0002938_white_spotting | 1.18841722 |
| 45 | MP0005253_abnormal_eye_physiology | 1.17248646 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.14764207 |
| 47 | MP0001485_abnormal_pinna_reflex | 1.14395032 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.14257422 |
| 49 | MP0005410_abnormal_fertilization | 1.11198732 |
| 50 | MP0000372_irregular_coat_pigmentation | 1.10595450 |
| 51 | MP0004130_abnormal_muscle_cell | 1.10038308 |
| 52 | MP0001905_abnormal_dopamine_level | 1.09485267 |
| 53 | MP0008995_early_reproductive_senescence | 1.08294233 |
| 54 | MP0003879_abnormal_hair_cell | 1.07690201 |
| 55 | MP0003638_abnormal_response/metabolism_ | 1.07668280 |
| 56 | MP0002736_abnormal_nociception_after | 1.06012602 |
| 57 | MP0002272_abnormal_nervous_system | 1.05165229 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 1.03891540 |
| 59 | MP0002572_abnormal_emotion/affect_behav | 1.02944870 |
| 60 | MP0001486_abnormal_startle_reflex | 1.02681785 |
| 61 | MP0005377_hearing/vestibular/ear_phenot | 1.02255165 |
| 62 | MP0003878_abnormal_ear_physiology | 1.02255165 |
| 63 | MP0003787_abnormal_imprinting | 1.01466278 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.01407408 |
| 65 | MP0000230_abnormal_systemic_arterial | 1.00914679 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.00347281 |
| 67 | MP0002733_abnormal_thermal_nociception | 1.00113235 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 0.98418486 |
| 69 | MP0001764_abnormal_homeostasis | 0.96363809 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 0.95190683 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 0.92598304 |
| 72 | MP0002064_seizures | 0.91615245 |
| 73 | MP0000026_abnormal_inner_ear | 0.91191319 |
| 74 | MP0005083_abnormal_biliary_tract | 0.90695967 |
| 75 | MP0001970_abnormal_pain_threshold | 0.90386794 |
| 76 | MP0002282_abnormal_trachea_morphology | 0.90074646 |
| 77 | MP0005386_behavior/neurological_phenoty | 0.87639855 |
| 78 | MP0004924_abnormal_behavior | 0.87639855 |
| 79 | MP0009643_abnormal_urine_homeostasis | 0.86248617 |
| 80 | MP0005670_abnormal_white_adipose | 0.85257646 |
| 81 | MP0003880_abnormal_central_pattern | 0.83974731 |
| 82 | MP0008775_abnormal_heart_ventricle | 0.82960392 |
| 83 | MP0005423_abnormal_somatic_nervous | 0.82026656 |
| 84 | MP0000427_abnormal_hair_cycle | 0.82002577 |
| 85 | MP0005195_abnormal_posterior_eye | 0.78117495 |
| 86 | MP0002067_abnormal_sensory_capabilities | 0.77808978 |
| 87 | MP0001984_abnormal_olfaction | 0.77688924 |
| 88 | MP0002063_abnormal_learning/memory/cond | 0.77245227 |
| 89 | MP0009046_muscle_twitch | 0.77094303 |
| 90 | MP0005636_abnormal_mineral_homeostasis | 0.76972520 |
| 91 | MP0003890_abnormal_embryonic-extraembry | 0.76694049 |
| 92 | MP0002653_abnormal_ependyma_morphology | 0.75289745 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.74845725 |
| 94 | MP0001440_abnormal_grooming_behavior | 0.74192333 |
| 95 | MP0003718_maternal_effect | 0.73945681 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.72367581 |
| 97 | MP0002078_abnormal_glucose_homeostasis | 0.72198817 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.70232115 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.70109186 |
| 100 | MP0009115_abnormal_fat_cell | 0.69200549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 4.30668679 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 4.16150181 |
| 3 | Congenital stationary night blindness (HP:0007642) | 3.92570834 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 3.65937226 |
| 5 | Attenuation of retinal blood vessels (HP:0007843) | 3.51419482 |
| 6 | Abnormality of midbrain morphology (HP:0002418) | 3.48247161 |
| 7 | Molar tooth sign on MRI (HP:0002419) | 3.48247161 |
| 8 | Pancreatic cysts (HP:0001737) | 3.33025977 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.19594885 |
| 10 | Complement deficiency (HP:0004431) | 3.14221136 |
| 11 | Joint hemorrhage (HP:0005261) | 3.13613510 |
| 12 | Abnormality of the renal cortex (HP:0011035) | 3.11894202 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.10204965 |
| 14 | Nephronophthisis (HP:0000090) | 3.09609509 |
| 15 | Pancreatic fibrosis (HP:0100732) | 3.02164003 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 3.00730958 |
| 17 | True hermaphroditism (HP:0010459) | 2.97397867 |
| 18 | Chronic hepatic failure (HP:0100626) | 2.96491236 |
| 19 | Hyperglycinuria (HP:0003108) | 2.96227127 |
| 20 | Hyperalaninemia (HP:0003348) | 2.88709071 |
| 21 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.88709071 |
| 22 | Abnormality of alanine metabolism (HP:0010916) | 2.88709071 |
| 23 | Xanthomatosis (HP:0000991) | 2.83986021 |
| 24 | Hyperglycinemia (HP:0002154) | 2.81308362 |
| 25 | Abolished electroretinogram (ERG) (HP:0000550) | 2.79567855 |
| 26 | Generalized aminoaciduria (HP:0002909) | 2.76699637 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 2.76602420 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.76602420 |
| 29 | Abnormal biliary tract physiology (HP:0012439) | 2.73601043 |
| 30 | Bile duct proliferation (HP:0001408) | 2.73601043 |
| 31 | Abnormality of the renal medulla (HP:0100957) | 2.72401641 |
| 32 | Pendular nystagmus (HP:0012043) | 2.69409282 |
| 33 | Abnormal drinking behavior (HP:0030082) | 2.65826726 |
| 34 | Polydipsia (HP:0001959) | 2.65826726 |
| 35 | Renal cortical cysts (HP:0000803) | 2.65688879 |
| 36 | Concave nail (HP:0001598) | 2.62626117 |
| 37 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.49044689 |
| 38 | Type II lissencephaly (HP:0007260) | 2.48634563 |
| 39 | Decreased circulating renin level (HP:0003351) | 2.47324911 |
| 40 | Delayed CNS myelination (HP:0002188) | 2.43229593 |
| 41 | Lissencephaly (HP:0001339) | 2.43221373 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.41769722 |
| 43 | Polyuria (HP:0000103) | 2.33848403 |
| 44 | Hyperventilation (HP:0002883) | 2.32147060 |
| 45 | Protruding tongue (HP:0010808) | 2.30658469 |
| 46 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.30093873 |
| 47 | Absent/shortened dynein arms (HP:0200106) | 2.30093873 |
| 48 | Patellar aplasia (HP:0006443) | 2.28292988 |
| 49 | Medial flaring of the eyebrow (HP:0010747) | 2.27380174 |
| 50 | Tubular atrophy (HP:0000092) | 2.26817277 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 2.26467189 |
| 52 | Hypothermia (HP:0002045) | 2.26358311 |
| 53 | Arthropathy (HP:0003040) | 2.24953674 |
| 54 | Abnormal urine output (HP:0012590) | 2.24139346 |
| 55 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.23560017 |
| 56 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.23560017 |
| 57 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18402774 |
| 58 | Abnormality of urine glucose concentration (HP:0011016) | 2.15613662 |
| 59 | Glycosuria (HP:0003076) | 2.15613662 |
| 60 | Abnormality of proline metabolism (HP:0010907) | 2.14548724 |
| 61 | Hydroxyprolinuria (HP:0003080) | 2.14548724 |
| 62 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.12971860 |
| 63 | Inability to walk (HP:0002540) | 2.11436065 |
| 64 | Renal Fanconi syndrome (HP:0001994) | 2.11231602 |
| 65 | Increased corneal curvature (HP:0100692) | 2.10452071 |
| 66 | Keratoconus (HP:0000563) | 2.10452071 |
| 67 | Spontaneous abortion (HP:0005268) | 2.10251485 |
| 68 | Epidermoid cyst (HP:0200040) | 2.08422573 |
| 69 | Cystic liver disease (HP:0006706) | 2.07966333 |
| 70 | Decreased central vision (HP:0007663) | 2.06662488 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.04646229 |
| 72 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.04392121 |
| 73 | Abnormality of serum amino acid levels (HP:0003112) | 2.00938965 |
| 74 | Breast hypoplasia (HP:0003187) | 1.98328591 |
| 75 | Gait imbalance (HP:0002141) | 1.97056358 |
| 76 | Chorioretinal atrophy (HP:0000533) | 1.90782301 |
| 77 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.90376454 |
| 78 | Stomach cancer (HP:0012126) | 1.88730340 |
| 79 | Optic disc pallor (HP:0000543) | 1.87501378 |
| 80 | Abnormality of the pons (HP:0007361) | 1.87165264 |
| 81 | Progressive inability to walk (HP:0002505) | 1.85694853 |
| 82 | Abnormality of renal excretion (HP:0011036) | 1.84671013 |
| 83 | Abnormal ciliary motility (HP:0012262) | 1.84118108 |
| 84 | Abnormality of complement system (HP:0005339) | 1.83884601 |
| 85 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83544685 |
| 86 | Furrowed tongue (HP:0000221) | 1.78878113 |
| 87 | Congenital primary aphakia (HP:0007707) | 1.78682620 |
| 88 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78341853 |
| 89 | Pigmentary retinal degeneration (HP:0001146) | 1.77976286 |
| 90 | Hypophosphatemic rickets (HP:0004912) | 1.77483696 |
| 91 | Pachygyria (HP:0001302) | 1.77158955 |
| 92 | Recurrent corneal erosions (HP:0000495) | 1.75510547 |
| 93 | Large for gestational age (HP:0001520) | 1.74928216 |
| 94 | Glomerulonephritis (HP:0000099) | 1.74140771 |
| 95 | Congenital, generalized hypertrichosis (HP:0004540) | 1.72824390 |
| 96 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72331652 |
| 97 | Hypoplasia of the pons (HP:0012110) | 1.70643295 |
| 98 | Acute encephalopathy (HP:0006846) | 1.69320829 |
| 99 | Ketosis (HP:0001946) | 1.67268523 |
| 100 | Hyperphosphaturia (HP:0003109) | 1.66681911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 3.67326938 |
| 2 | ADRBK2 | 3.62186159 |
| 3 | ACVR1B | 3.57713161 |
| 4 | WNK4 | 3.50165190 |
| 5 | INSRR | 3.19860806 |
| 6 | CASK | 3.11612295 |
| 7 | WNK3 | 3.09233891 |
| 8 | ZAK | 2.97737909 |
| 9 | BMPR1B | 2.70462455 |
| 10 | PINK1 | 2.67908088 |
| 11 | FRK | 2.64052151 |
| 12 | MAP4K2 | 2.29829242 |
| 13 | TAOK3 | 2.20369259 |
| 14 | GRK1 | 2.18739582 |
| 15 | DAPK2 | 2.16445671 |
| 16 | NTRK3 | 1.99439796 |
| 17 | MARK1 | 1.97322077 |
| 18 | TXK | 1.81568139 |
| 19 | STK39 | 1.74111196 |
| 20 | MAPK13 | 1.65098711 |
| 21 | PIK3CA | 1.53529025 |
| 22 | MUSK | 1.50354357 |
| 23 | ADRBK1 | 1.39418807 |
| 24 | OXSR1 | 1.37471882 |
| 25 | TGFBR1 | 1.27946371 |
| 26 | NUAK1 | 1.23385536 |
| 27 | MAP3K4 | 1.20137787 |
| 28 | DYRK2 | 1.18393379 |
| 29 | MAP2K6 | 1.17533772 |
| 30 | SIK2 | 1.05481956 |
| 31 | PAK3 | 0.99550552 |
| 32 | FGFR2 | 0.97938301 |
| 33 | ERBB2 | 0.97678021 |
| 34 | PRKCG | 0.97505959 |
| 35 | TNIK | 0.97298285 |
| 36 | BCKDK | 0.92073391 |
| 37 | PHKG2 | 0.89836817 |
| 38 | PHKG1 | 0.89836817 |
| 39 | MAP2K7 | 0.88413987 |
| 40 | PNCK | 0.83306613 |
| 41 | ABL2 | 0.81198029 |
| 42 | MAP2K4 | 0.80177254 |
| 43 | MAPKAPK3 | 0.79554053 |
| 44 | TNK2 | 0.78277330 |
| 45 | NTRK2 | 0.77147101 |
| 46 | PRKAA2 | 0.76595872 |
| 47 | TIE1 | 0.76574881 |
| 48 | VRK1 | 0.75127859 |
| 49 | EPHB2 | 0.72842169 |
| 50 | CAMKK2 | 0.66829862 |
| 51 | PRKACA | 0.64122843 |
| 52 | CAMKK1 | 0.63126125 |
| 53 | RPS6KA5 | 0.61734488 |
| 54 | NME1 | 0.60837826 |
| 55 | MAPK15 | 0.60463166 |
| 56 | STK11 | 0.57806138 |
| 57 | CAMK1 | 0.57344931 |
| 58 | DYRK1B | 0.57208600 |
| 59 | MAP2K1 | 0.56956152 |
| 60 | PRKCE | 0.56559308 |
| 61 | PRKAA1 | 0.55465008 |
| 62 | GRK7 | 0.55010697 |
| 63 | OBSCN | 0.53971887 |
| 64 | PRKCZ | 0.52785621 |
| 65 | CAMK2A | 0.52440006 |
| 66 | PRKACG | 0.52349845 |
| 67 | TEC | 0.51848124 |
| 68 | DYRK1A | 0.51453378 |
| 69 | MAP2K2 | 0.51272470 |
| 70 | PRKG1 | 0.51060973 |
| 71 | EPHA4 | 0.46755903 |
| 72 | MAP3K11 | 0.46379846 |
| 73 | PRKCQ | 0.45826489 |
| 74 | IKBKB | 0.45048674 |
| 75 | PKN1 | 0.44793202 |
| 76 | STK38L | 0.44051012 |
| 77 | CHUK | 0.43839658 |
| 78 | PRKD2 | 0.41907199 |
| 79 | PRKACB | 0.38418437 |
| 80 | PRKG2 | 0.37479148 |
| 81 | EPHA3 | 0.37291264 |
| 82 | PTK2B | 0.36066833 |
| 83 | KIT | 0.35683684 |
| 84 | PRKCA | 0.35475084 |
| 85 | RPS6KA6 | 0.35217347 |
| 86 | CSNK1A1 | 0.34868441 |
| 87 | WNK1 | 0.33430009 |
| 88 | PLK4 | 0.33177119 |
| 89 | ITK | 0.33028647 |
| 90 | CAMK1D | 0.32721719 |
| 91 | MAPKAPK5 | 0.32719652 |
| 92 | CSNK1D | 0.31581273 |
| 93 | IGF1R | 0.30797568 |
| 94 | CAMK1G | 0.30723183 |
| 95 | CSNK1E | 0.28304497 |
| 96 | NEK1 | 0.28303859 |
| 97 | CLK1 | 0.27082333 |
| 98 | SYK | 0.25153014 |
| 99 | MATK | 0.24063868 |
| 100 | LYN | 0.23978657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.63009652 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.14162949 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.82243028 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.67458820 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54798139 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.53183657 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.52517593 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.47204769 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.45983840 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.35353957 |
| 11 | Retinol metabolism_Homo sapiens_hsa00830 | 2.30620995 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.15025661 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09837775 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05091660 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.03634557 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.98975912 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.93604521 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.93391207 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.86327550 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.82948457 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.78135210 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.66908517 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.63733838 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.63568672 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.61732802 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.58690815 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58163555 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54894756 |
| 29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.50691894 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.49675891 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46654830 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.41518399 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.38480295 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.35666068 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29862332 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27557645 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27093535 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25243556 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24462875 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.22674755 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15488364 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.14422502 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14392475 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10951443 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07453481 |
| 46 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05886255 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03506547 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02904480 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99817712 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97339994 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95755155 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90475719 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89491334 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88677850 |
| 55 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87328593 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84170341 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84072385 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83567219 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81807660 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80531630 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79710456 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78388156 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71936754 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71004721 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68744839 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67490073 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66987922 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65841852 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.65333034 |
| 70 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65172726 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62231179 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60775696 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58845590 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55367981 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.54021023 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54018284 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53490757 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52702158 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52475540 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47629167 |
| 81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46280604 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43947042 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 0.42040488 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41831076 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38957827 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37850553 |
| 87 | Ribosome_Homo sapiens_hsa03010 | 0.37639367 |
| 88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35786667 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.35696149 |
| 90 | RNA polymerase_Homo sapiens_hsa03020 | 0.35037273 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34649385 |
| 92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.33662401 |
| 93 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.29065970 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28789887 |
| 95 | Protein export_Homo sapiens_hsa03060 | 0.26919545 |
| 96 | Cocaine addiction_Homo sapiens_hsa05030 | 0.25417734 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.21463213 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.18981919 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.15995979 |
| 100 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.15914656 |

